Medicinova (MNOV)
NASDAQ:MNOV
Holding MNOV?
Track your performance easily

Medicinova (MNOV) Income Statement

290 Followers

Medicinova Income Statement

Last quarter (Q ), Medicinova's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Medicinova's net income was $-2.63M. See Medicinova’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.00M$ 1.00M-$ 4.04M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 1.00M$ 1.00M-$ 4.04M--
Operating Expense
$ 10.82M$ 10.90M$ -14.63M$ 14.25M$ 14.18M$ 14.03M
Operating Income
$ -9.82M$ -9.90M$ -14.63M$ -10.22M$ -14.18M$ -14.03M
Net Non Operating Interest Income Expense
$ 1.71M$ 1.83M$ 809.67K$ 143.63K$ 361.18K$ 1.15M
Other Income Expense
$ 49.44K$ -502.87K$ 247.28K$ 59.50K$ -38.40K$ -46.16K
Pretax Income
$ -11.16M$ -8.57M$ -14.07M$ -10.13M$ -13.86M$ -12.93M
Tax Provision
$ 3.05K$ 3.05K$ 2.82K$ 2.57K$ -1.65K$ 12.66K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.58M$ -8.57M$ -14.07M$ -10.13M$ -13.85M$ -12.94M
Basic EPS
$ -0.16$ -0.17$ -0.29$ -0.21$ -0.31$ -0.30
Diluted EPS
$ -0.16$ -0.17$ -0.29$ -0.21$ -0.31$ -0.30
Basic Average Shares
$ 196.18M$ 49.05M$ 49.05M$ 48.60M$ 44.41M$ 43.16M
Diluted Average Shares
$ 196.18M$ 49.05M$ 49.05M$ 48.60M$ 44.41M$ 43.16M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 10.82M$ 10.90M$ -14.63M$ 14.25M$ 14.18M$ 14.03M
Net Income From Continuing And Discontinued Operation
$ -8.16M$ -8.57M$ -14.07M$ -10.13M$ -13.85M$ -12.94M
Normalized Income
$ -9.21M$ -6.77M--$ -13.85M$ -12.94M
Interest Expense
------
EBIT
$ -12.80M$ -9.90M$ -14.07M$ -10.13M$ -14.18M$ -14.03M
EBITDA
$ -13.65M$ -9.88M$ -14.05M$ -10.11M$ -14.16M$ -14.01M
Currency in USD

Medicinova Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis